adverse drug reactions (ADRs)

Improvements in recording brand and batch numbers for biologic medicines are needed if patient safety is to be ensured, a new study suggests. Read more


Daniel Streetman from Wolters Kluwer discusses the potential for pharmacogenomics to transform prescribed drugs and reduce instances of adverse drug reactions. Read more


A recent study has revealed that an estimated 237 million medication errors occur in the NHS in England yearly, which, in addition to avoidable adverse drug reactions (ADRs), account for many avoidable deaths. Read more